Literature DB >> 27272561

Mutation Profiling Indicates High Grade Prostatic Intraepithelial Neoplasia as Distant Precursors of Adjacent Invasive Prostatic Adenocarcinoma.

Sean J Gerrin1, Adam G Sowalsky2,3, Steven P Balk2, Huihui Ye1.   

Abstract

INTRODUCTION: High Grade Prostatic Intraepithelial Neoplasia (HGPIN) is the putative precursor lesion to prostatic adenocarcinoma (PCa), but the precise relationship between HGPIN and PCa remains unclear.
METHODS: We performed a molecular case study in which we studied mutation profiles of six tumor-associated HGPIN lesions in a single case of TMPRSS2:ERG fusion positive Gleason score 7 PCa that we had previously mapped for somatic mutations in adjacent Gleason patterns 3 and 4 foci, using microdissection and targeted deep-sequencing.
RESULTS: A total of 32 tumor-specific mutated sites were successfully amplified and sequenced, including 25 truncal mutations and 7 mutations that were specific to either the Gleason pattern 3 or pattern 4 foci. All six HGPIN foci shared the same tumor-specific TMPRSS2:ERG fusion breakpoint, establishing that they were all clonally related to the adjacent invasive tumor. Among the 32 gene targets mutated in the invasive tumor, only mutation of the OR2AP1 gene, a truncal mutation, was found in a single focus of HGPIN. The remaining gene targets that were successfully sequenced were wild-type in all other HGPIN foci. DISCUSSION: This study demonstrates the feasibility of targeted mutation profiling of HGPIN lesions, which will be important to understand PCa tumorigenesis. The results in this case, showing a remarkable absence of truncal mutations in HGPIN lesions bearing the tumor-specific ERG fusion, indicate HGPIN lesions may be relatively stable genetically and argue against a stepwise clonal evolution model of HGPIN to PCa. Prostate 76:1227-1236, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  carcinoma; high grade prostatic intraepithelial neoplasia; mutation; precursor; prostate

Mesh:

Year:  2016        PMID: 27272561      PMCID: PMC5507580          DOI: 10.1002/pros.23212

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  29 in total

Review 1.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Authors:  Jonathan I Epstein; William C Allsbrook; Mahul B Amin; Lars L Egevad
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

2.  PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.

Authors:  Tarek A Bismar; Maisa Yoshimoto; Robin T Vollmer; Qiuli Duan; Matthew Firszt; Jacques Corcos; Jeremy A Squire
Journal:  BJU Int       Date:  2011-02       Impact factor: 5.588

Review 3.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Authors:  Jonathan I Epstein; Lars Egevad; Mahul B Amin; Brett Delahunt; John R Srigley; Peter A Humphrey
Journal:  Am J Surg Pathol       Date:  2016-02       Impact factor: 6.394

4.  Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer.

Authors:  Stephen J Murphy; Robert J Karnes; Farhad Kosari; B Edgardo R Parilla Castellar; Benjamin R Kipp; Sarah H Johnson; Simone Terra; Faye R Harris; Geoffrey C Halling; Janet L Schaefer Klein; Aqsa Nasir; Eric Bergstrahl; Laureano J Rangel; William R Sukov; George Vasmatzis; John C Cheville
Journal:  Mod Pathol       Date:  2015-11-27       Impact factor: 7.842

5.  TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.

Authors:  Kyung Park; James T Dalton; Ramesh Narayanan; Christopher E Barbieri; Michael L Hancock; David G Bostwick; Mitchell S Steiner; Mark A Rubin
Journal:  J Clin Oncol       Date:  2013-12-02       Impact factor: 44.544

6.  Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.

Authors:  Koh-Ichi Nakashiro; Yoshiki Hayashi; Ryoichi Oyasu
Journal:  Oncol Rep       Date:  2003 Sep-Oct       Impact factor: 3.906

7.  Clonal progression of prostate cancers from Gleason grade 3 to grade 4.

Authors:  Adam G Sowalsky; Huihui Ye; Glenn J Bubley; Steven P Balk
Journal:  Cancer Res       Date:  2012-11-30       Impact factor: 12.701

8.  Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.

Authors:  J Qian; D G Bostwick; S Takahashi; T J Borell; J F Herath; M M Lieber; R B Jenkins
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

9.  Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.

Authors:  R B Myers; S Srivastava; D K Oelschlager; W E Grizzle
Journal:  J Natl Cancer Inst       Date:  1994-08-03       Impact factor: 13.506

10.  The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.

Authors:  H Artee Luchman; Hallgrimur Benediktsson; Michelle L Villemaire; Alan C Peterson; Frank R Jirik
Journal:  PLoS One       Date:  2008-12-15       Impact factor: 3.240

View more
  6 in total

Review 1.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

Review 2.  Molecular correlates of intermediate- and high-risk localized prostate cancer.

Authors:  Huihui Ye; Adam G Sowalsky
Journal:  Urol Oncol       Date:  2018-03-02       Impact factor: 3.498

3.  Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.

Authors:  Scott Wilkinson; Huihui Ye; Fatima Karzai; Stephanie A Harmon; Nicholas T Terrigino; David J VanderWeele; John R Bright; Rayann Atway; Shana Y Trostel; Nicole V Carrabba; Nichelle C Whitlock; Stephanie M Walker; Rosina T Lis; Houssein Abdul Sater; Brian J Capaldo; Ravi A Madan; James L Gulley; Guinevere Chun; Maria J Merino; Peter A Pinto; Daniela C Salles; Harsimar B Kaur; Tamara L Lotan; David J Venzon; Peter L Choyke; Baris Turkbey; William L Dahut; Adam G Sowalsky
Journal:  Eur Urol       Date:  2021-03-27       Impact factor: 20.096

Review 4.  Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities.

Authors:  Levent Trabzonlu; Ibrahim Kulac; Qizhi Zheng; Jessica L Hicks; Michael C Haffner; William G Nelson; Karen S Sfanos; Onur Ertunc; Tamara L Lotan; Christopher M Heaphy; Alan K Meeker; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 5.  Cellular senescence as a possible link between prostate diseases of the ageing male.

Authors:  Gaelle Fiard; Vasilis Stavrinides; Emma S Chambers; Susan Heavey; Alex Freeman; Rhys Ball; Arne N Akbar; Mark Emberton
Journal:  Nat Rev Urol       Date:  2021-07-22       Impact factor: 14.432

Review 6.  Understanding and targeting prostate cancer cell heterogeneity and plasticity.

Authors:  Dean G Tang
Journal:  Semin Cancer Biol       Date:  2021-11-26       Impact factor: 17.012

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.